Alex Bobik Selected Research

B-Cell Activation Factor Receptor

2/2017	Opposing roles of B lymphocyte subsets in atherosclerosis.
1/2013	BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.
1/2012	Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex Bobik Research Topics

Disease

33	Atherosclerosis 01/2022 - 12/2002
13	Inflammation (Inflammations) 11/2017 - 12/2003
10	Atherosclerotic Plaque (Atheroma) 01/2022 - 02/2004
8	Myocardial Infarction 01/2021 - 08/2003
7	Neointima 05/2009 - 06/2002
5	Rupture 01/2022 - 01/2002
4	Stroke (Strokes) 01/2021 - 02/2016
3	Thrombosis (Thrombus) 01/2022 - 01/2014
3	Pathologic Constriction (Stenosis) 01/2022 - 09/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 08/2004
3	Hypertension (High Blood Pressure) 07/2004 - 05/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2005
2	Infections 12/2017 - 11/2017
2	Necrosis 12/2016 - 02/2016
2	Insulin Resistance 03/2015 - 04/2011
2	Obesity 03/2015 - 04/2011
2	Body Weight (Weight, Body) 01/2012 - 09/2011
2	Infarction (Infarctions) 06/2011 - 04/2006
2	Hyperplasia 05/2009 - 09/2004
2	Stable Angina 08/2004 - 08/2003
1	Abdominal Aortic Aneurysm 01/2022
1	Ischemic Stroke 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2017
1	Chest Pain (Chest Pains) 12/2016
1	Ischemia 12/2016
1	Weight Gain 03/2015
1	Fatty Liver 03/2015
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2014
1	Acute Coronary Syndrome 04/2012
1	Arteritis 01/2012
1	Reperfusion Injury 06/2011

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2006
11	CytokinesIBA 01/2018 - 12/2003
9	LipidsIBA 01/2022 - 11/2008
7	ApolipoproteinsIBA 01/2021 - 08/2006
5	Immunoglobulin M (IgM)IBA 01/2018 - 09/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 08/2006 - 06/2002
4	CholesterolIBA 01/2022 - 10/2006
4	Monoclonal AntibodiesIBA 01/2022 - 01/2013
4	CollagenIBA 09/2011 - 09/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2009 - 12/2003
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
3	Immunoglobulin G (IgG)IBA 01/2021 - 02/2017
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2017 - 11/2008
3	B-Cell Activation Factor ReceptorIBA 02/2017 - 01/2012
3	HMGB1 Protein (HMG1)IBA 11/2015 - 02/2011
3	Superoxides (Superoxide)IBA 09/2004 - 12/2002
2	Angiotensin IIIBA 01/2022 - 07/2004
2	oxidized low density lipoproteinIBA 02/2017 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 01/2014
2	AllergensIBA 02/2016 - 02/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2015 - 08/2004
2	AntibodiesIBA 04/2014 - 01/2013
2	PerforinIBA 04/2014 - 03/2013
2	Granzymes (Granzyme)IBA 04/2014 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 08/2004
2	Neutralizing AntibodiesIBA 02/2011 - 01/2006
2	C-Reactive ProteinIBA 07/2009 - 08/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2008 - 04/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2007 - 06/2002
2	AnionsIBA 09/2004 - 04/2004
2	Endothelin-1 (Endothelin 1)IBA 08/2004 - 02/2004
1	CyclodextrinsIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Factor XIIa (Coagulation Factor XIIa)IBA 01/2022
1	AlarminsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Cytotoxins (Cytolysins)IBA 11/2017
1	ChemokinesIBA 11/2017
1	Therapeutic UsesIBA 02/2017
1	Fatty Acid Binding Protein 3IBA 12/2016
1	Troponin IIBA 12/2016
1	Evans Blue (Blue, Evans)FDA Link 12/2016
1	Fatty Acid-Binding ProteinsIBA 12/2016
1	tesmilifene (DPPE)IBA 02/2016
1	phosphorylethanolamine (phosphoethanolamine)IBA 02/2016
1	Liposomes (Liposome)IBA 06/2015
1	PhosphatidylserinesIBA 06/2015
1	Diphtheria ToxinIBA 01/2014
1	P-SelectinIBA 01/2014
1	SelectinsIBA 01/2014
1	MicroRNAs (MicroRNA)IBA 07/2013
1	Pharmaceutical PreparationsIBA 07/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2013
1	InterferonsIBA 03/2013
1	InterleukinsIBA 03/2013
1	Immunoglobulin E (IgE)IBA 02/2012
1	Polystyrenes (Polystyrene)IBA 02/2012
1	Proteoglycans (Proteoglycan)IBA 09/2011
1	Macrophage Migration-Inhibitory FactorsIBA 06/2011

Therapy/Procedure

6	Therapeutics 01/2022 - 09/2011
2	Splenectomy 01/2018 - 06/2015
1	Ligation 01/2022
1	Precision Medicine 01/2022
1	Immunomodulation 12/2017
1	Immunotherapy 11/2017